101799-75-1

Basic information

• Product Name: α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester
• Synonyms: α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester
• CAS NO: 101799-75-1
• Molecular Weight: 302.25
• Mol File: 101799-75-1.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 397.1±42.0 °C(Predicted)
• Density: 1.281±0.06 g/cm3(Predicted)
• CAS DataBase Reference: α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester(101799-75-1)
• EPA Substance Registry System: α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester(101799-75-1)

Safety Data

• Hazardous Substances Data: 101799-75-1(Hazardous Substances Data)

Upstream product

• 446-17-3 2,4,5-trifluorobenzoic acid 
• 104600-15-9 (2,4,5-trifluorobenzoyl)propanedioic acid, diethyl ester 
• 88419-56-1 2,4,5-trifluorobenzoyl chloride 
• 98349-24-7 ethyl 2,4,5-trifluorobenzoylacetate 
• 122-51-0 orthoformic acid triethyl ester 

Downstream Products

• 122551-44-4 ethyl α-<<<2-(difluoromethoxy)phenyl>amino>methylene>-2,4,5-trifluoro-β-oxo-benzenepropionate ester 
• 122551-45-5 (Z)-3-(4-Difluoromethoxy-phenylamino)-2-(2,4,5-trifluoro-benzoyl)-acrylic acid ethyl ester 
• 122551-46-6 (Z)-3-(3,4-Bis-difluoromethoxy-phenylamino)-2-(2,4,5-trifluoro-benzoyl)-acrylic acid ethyl ester 
• 101799-76-2 3-Cyclopropylamino-2-(2,4,5-trifluorbenzoyl)acrylsaeure-ethylester 
• 164151-32-0 ethyl 3-(5-fluoro-2-pyridyl)amino-2-(2,4,5-trifluorobenzoyl)acrylate 
• 875712-88-2 (E)-1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isobutyryloxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 875712-88-2 (Z)-1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isobutyryloxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 875712-88-2 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isobutyryloxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 189279-58-1 delafloxacin 
• 906088-96-8 C₁₇H₁₁F₄N₃O₃ 
• 442526-91-2 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isobutyryloxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 
• 108115-66-8 ethyl 3-(4-fuoroanilino)-2-(2,4,5-trifuorobenzoyl)acrylate 
• 108138-16-5 1-(p-fluorophenyl)-6,7-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid ethyl ester 
• 98106-17-3 difloxacin 

Relevant articles and documents

Chlorination at the 8-position of a functionalized quinolone and the synthesis of quinolone antibiotic ABT-492

The total synthesis of quinolone antibiotic ABT-492 has been achieved in 67% yield over nine steps from 2,4,5-trifluorobenzoic acid. The highlights of this synthesis include a novel chemoselective chlorination at the 8-position of a highly elaborated quinolone core. In addition, a Lewis acid promoted cyclization reaction to form the quinolone heterocycle was developed which was incorporated into a one-pot, three-step cyclization/coupling/protection sequence that proceeds in 93% yield.

Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone

Fluoroquinolones substituted with N-1 biphenyl and napthyl groups were discovered to act as catalytically inhibitors of human topoisomerases I and II, and to possess anti-proliferative activity in vivo. Structural requirements for these novel quinolones t

Syntheses of new pyridonecarboxylic acid derivatives containing 1- or 2- naphthyl substituents at N-1 and their anti-HIV-RT activities

A series of new pyridonecarboxylic acid derivatives containing 1- or 2- naphthyl substituents at N-1 were synthesized at their in vitro anti-HIV-RT activities were evaluated. Several compounds in this series showed better activity than Atevirdine.

A kind of improved [...] preparation method (by machine translation)

The invention belongs to the field of medical synthesis, in particular to a kind of improved [...] preparation method. The technology of this invention can avoid a 4 - benzopyran [...] formation of impurities, and follow-up substituted, cyclized, butt joi

QUINOLONE-BASED COMPOUNDS WITH ANTICANCER ACTIVITY

Embodiments are directed to compounds of the formulae (I), (Ia), (Ib), (II), (IIa) (III), (IV), (V), and (VI); methods for treating cancer with one or more compounds of the formulae (I), (Ia), (Ib), (II), (IIa); (III), (IV), (V), and (VI); and methods for